Comparative lung delivery of salbutamol given via Turbuhaler and Diskus dry powder inhaler devices

European Journal of Clinical Pharmacology

Volumn 53, Issue 1, 1997, Pages 47-49

  Lipworth, B J ^a   Clark, D J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Bioavailability; Diskus; Dry powder inhaler; Lung; Salbutamol; Turbuhaler

Indexed keywords

SALBUTAMOL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DOSAGE FORM; DRY POWDER; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; INHALER; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VOLUNTEER;

ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DRUG DELIVERY SYSTEMS; HEART RATE; HUMANS; LUNG; NEBULIZERS AND VAPORIZERS; POWDERS; SINGLE-BLIND METHOD;

EID: 0030920476     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050335     Document Type: Article

References (13)

1. Partridge MR (1994) Metered-dose inhalers and CFCs: what respiratory physicians need to know. Respir Med 88: 645-647
2. Olsson B (1995) Aerosol particle generation from dry powder inhalers: can they equal pressurised metered dose inhalers? J Aerosol Med 8 [Suppl 3]: S13-18
3. Borgstrom L, Bondesson E, Moren F, Trofast E, Newman SP (1994) Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal volunteers. Eur Respir J 7: 68-73
4. Ekstrom T, Andersson A, Skedinger M, Lindbladh C, Stahl E (1995) Dose potency relationship of terbutaline inhaled via Turbuhaler or via a pressurised metered dose inhaler. Ann Allergy Asthma Immunol 74: 328-332
5. Borgstrom L, Derom E, Stahl E, Wahlin-Boll E, Pauwels R (1996) The inhalation device influences lung deposition and bronchodilating effect of terbutaline. Am J Respir Crit Care Med 153: 1636-1640
6. Crompton GK (1982) Problems patients having used pressurised aerosol inhalers. Eur J Respir Dis 63 [Suppl. 119]: 101-104
7. Pedersen S (1994) Choice of inhalation therapy in asthmatics. Eur Respir Rev 4: 86-89
8. Siafakas NM, Bouros D (1994) Choice of inhalation therapy in adults. Eur Respir Rev 4: 78-81
9. Clark DJ, Lipworth BJ (1996) Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol. Br J Clin Pharmacol 41: 247-249
10. Clark DJ, Gordon-Smith J, McPhate G, Clark G, Lipworth BJ (1996) Lung bioavailability of generic and innovator salbutamol metered dose inhalers. Thorax 51: 325-326
11. Clark DJ, Lipworth BJ (1996) Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device. Thorax 51: 981-984
12. Lipworth BJ, Clark RA, Dhillon DP, Moreland TA, Struthers AD, Clark GA, McDevitt DG (1989) Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol 37: 567-571
13. Lipworth BJ (1996) Pharmacokinetics of inhaled drugs. Br J Clin Pharmacol 42: 697-705